Annual CFO
-$78.20 M
+$8.75 M+10.07%
December 31, 2023
Summary
- As of February 26, 2025, MGNX annual cash flow from operations is -$78.20 million, with the most recent change of +$8.75 million (+10.07%) on December 31, 2023.
- During the last 3 years, MGNX annual CFO has risen by +$33.69 million (+30.11%).
- MGNX annual CFO is now -642.90% below its all-time high of $14.40 million, reached on December 31, 2017.
Performance
MGNX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$60.16 M
+$104.65 M+235.24%
September 30, 2024
Summary
- As of February 26, 2025, MGNX quarterly cash flow from operations is $60.16 million, with the most recent change of +$104.65 million (+235.24%) on September 30, 2024.
- Over the past year, MGNX quarterly CFO has stayed the same.
- MGNX quarterly CFO is now -46.21% below its all-time high of $111.84 million, reached on December 31, 2017.
Performance
MGNX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$58.00 M
+$95.41 M+62.19%
September 30, 2024
Summary
- As of February 26, 2025, MGNX TTM cash flow from operations is -$58.00 million, with the most recent change of +$95.41 million (+62.19%) on September 30, 2024.
- Over the past year, MGNX TTM CFO has stayed the same.
- MGNX TTM CFO is now -414.53% below its all-time high of $18.44 million, reached on March 31, 2018.
Performance
MGNX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MGNX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.1% | 0.0% | 0.0% |
| 3 y3 years | +30.1% | +204.3% | +66.4% |
| 5 y5 years | +49.0% | +204.3% | +66.4% |
MGNX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.6% | at high | +204.3% | -1265.7% | +67.0% |
| 5 y | 5-year | at high | +45.6% | at high | +204.3% | -1265.7% | +67.0% |
| alltime | all time | -642.9% | +49.0% | -46.2% | +204.2% | -414.5% | +67.0% |
MacroGenics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $60.16 M(-235.2%) | -$58.00 M(-62.2%) |
| Jun 2024 | - | -$44.48 M(-2.5%) | -$153.41 M(+38.2%) |
| Mar 2024 | - | -$45.64 M(+62.8%) | -$111.02 M(+42.0%) |
| Dec 2023 | -$78.20 M(-10.1%) | -$28.04 M(-20.5%) | -$78.20 M(+275.1%) |
| Sep 2023 | - | -$35.25 M(+1587.2%) | -$20.85 M(-519.0%) |
| Jun 2023 | - | -$2.09 M(-83.7%) | $4.98 M(-111.8%) |
| Mar 2023 | - | -$12.83 M(-143.8%) | -$42.10 M(-51.6%) |
| Dec 2022 | -$86.96 M(-39.5%) | $29.32 M(-411.2%) | -$86.96 M(-49.0%) |
| Sep 2022 | - | -$9.42 M(-80.8%) | -$170.59 M(-3.1%) |
| Jun 2022 | - | -$49.16 M(-14.8%) | -$175.96 M(+2.0%) |
| Mar 2022 | - | -$57.70 M(+6.2%) | -$172.49 M(+19.9%) |
| Dec 2021 | -$143.83 M(+28.5%) | -$54.31 M(+267.1%) | -$143.83 M(+51.3%) |
| Sep 2021 | - | -$14.79 M(-67.6%) | -$95.05 M(-10.3%) |
| Jun 2021 | - | -$45.69 M(+57.4%) | -$105.94 M(+9.4%) |
| Mar 2021 | - | -$29.04 M(+424.8%) | -$96.79 M(-13.5%) |
| Dec 2020 | -$111.90 M(-16.7%) | -$5.53 M(-78.5%) | -$111.90 M(-22.5%) |
| Sep 2020 | - | -$25.68 M(-29.7%) | -$144.41 M(+6.1%) |
| Jun 2020 | - | -$36.55 M(-17.2%) | -$136.12 M(-8.3%) |
| Mar 2020 | - | -$44.14 M(+16.0%) | -$148.41 M(+10.5%) |
| Dec 2019 | -$134.27 M(-12.4%) | -$38.04 M(+118.8%) | -$134.27 M(+8.8%) |
| Sep 2019 | - | -$17.39 M(-64.4%) | -$123.45 M(-13.7%) |
| Jun 2019 | - | -$48.84 M(+62.8%) | -$143.05 M(-5.9%) |
| Mar 2019 | - | -$30.00 M(+10.2%) | -$151.94 M(-0.8%) |
| Dec 2018 | -$153.23 M | -$27.23 M(-26.4%) | -$153.23 M(+982.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$36.98 M(-35.9%) | -$14.16 M(+65.9%) |
| Jun 2018 | - | -$57.73 M(+84.5%) | -$8.54 M(-146.3%) |
| Mar 2018 | - | -$31.30 M(-128.0%) | $18.44 M(+28.0%) |
| Dec 2017 | $14.40 M(-133.0%) | $111.84 M(-456.7%) | $14.40 M(-111.5%) |
| Sep 2017 | - | -$31.35 M(+1.9%) | -$125.77 M(+181.8%) |
| Jun 2017 | - | -$30.75 M(-13.0%) | -$44.63 M(-5.2%) |
| Mar 2017 | - | -$35.33 M(+24.7%) | -$47.10 M(+7.8%) |
| Dec 2016 | -$43.68 M(+219.7%) | -$28.33 M(-156.9%) | -$43.68 M(+10.6%) |
| Sep 2016 | - | $49.79 M(-249.8%) | -$39.51 M(-59.2%) |
| Jun 2016 | - | -$33.23 M(+4.1%) | -$96.92 M(+8.7%) |
| Mar 2016 | - | -$31.91 M(+32.1%) | -$89.16 M(+552.7%) |
| Dec 2015 | -$13.66 M(-58.3%) | -$24.16 M(+216.4%) | -$13.66 M(+41.3%) |
| Sep 2015 | - | -$7.63 M(-70.0%) | -$9.67 M(-40.9%) |
| Jun 2015 | - | -$25.46 M(-158.4%) | -$16.37 M(-430.8%) |
| Mar 2015 | - | $43.59 M(-316.2%) | $4.95 M(-115.1%) |
| Dec 2014 | -$32.76 M(+131.2%) | -$20.16 M(+40.7%) | -$32.76 M(+137.7%) |
| Sep 2014 | - | -$14.33 M(+245.3%) | -$13.78 M(-1113.9%) |
| Jun 2014 | - | -$4.15 M(-170.5%) | $1.36 M(-130.6%) |
| Mar 2014 | - | $5.89 M(-597.1%) | -$4.44 M(-68.7%) |
| Dec 2013 | -$14.17 M(+115.3%) | -$1.18 M(-246.7%) | -$14.17 M(+9.1%) |
| Sep 2013 | - | $807.00 K(-108.1%) | -$12.99 M(-5.8%) |
| Jun 2013 | - | -$9.95 M(+158.4%) | -$13.79 M(+258.4%) |
| Mar 2013 | - | -$3.85 M | -$3.85 M |
| Dec 2012 | -$6.58 M(-197.4%) | - | - |
| Dec 2011 | $6.76 M | - | - |
FAQ
- What is MacroGenics annual cash flow from operations?
- What is the all time high annual CFO for MacroGenics?
- What is MacroGenics annual CFO year-on-year change?
- What is MacroGenics quarterly cash flow from operations?
- What is the all time high quarterly CFO for MacroGenics?
- What is MacroGenics quarterly CFO year-on-year change?
- What is MacroGenics TTM cash flow from operations?
- What is the all time high TTM CFO for MacroGenics?
- What is MacroGenics TTM CFO year-on-year change?
What is MacroGenics annual cash flow from operations?
The current annual CFO of MGNX is -$78.20 M
What is the all time high annual CFO for MacroGenics?
MacroGenics all-time high annual cash flow from operations is $14.40 M
What is MacroGenics annual CFO year-on-year change?
Over the past year, MGNX annual cash flow from operations has changed by +$8.75 M (+10.07%)
What is MacroGenics quarterly cash flow from operations?
The current quarterly CFO of MGNX is $60.16 M
What is the all time high quarterly CFO for MacroGenics?
MacroGenics all-time high quarterly cash flow from operations is $111.84 M
What is MacroGenics quarterly CFO year-on-year change?
Over the past year, MGNX quarterly cash flow from operations has changed by $0.00 (0.00%)
What is MacroGenics TTM cash flow from operations?
The current TTM CFO of MGNX is -$58.00 M
What is the all time high TTM CFO for MacroGenics?
MacroGenics all-time high TTM cash flow from operations is $18.44 M
What is MacroGenics TTM CFO year-on-year change?
Over the past year, MGNX TTM cash flow from operations has changed by $0.00 (0.00%)